Russia’s Sputnik V COVID-19 Vaccine Starts EU Rolling Review
‘A Major Step’ Towards Approval, Say Backers
The Russian backers of the vaccine’s development say that if it receives a marketing authorization in the EU, distribution could begin in June this year.
You may also be interested in...
While speculation mounts about Serum Institute being next in line for an RDIF partnership, Gland Pharma and Strides unit Stelis sign up to make COVID-19 vaccine Sputnik V. Part of the 550 million dose output tied up from India so far could be consumed domestically, but exports are a possibility as demand from European countries is set to jump.
Politics are never far from the surface where coronavirus vaccines are concerned, as demonstrated by recent comments by the Sputnik V developers.
While the EU attempts to accelerate the pace of its unified approach to vaccine roll-out, some eastern European countries are taking their own decisions.